Realnova Healthcare

FEATURES OF Ceftriaxone 500 mg Injection I.P.

✔ Broad-Spectrum Antibiotic
Effective against a wide range of gram-positive and gram-negative bacteria.

✔ Third-Generation Cephalosporin
Provides enhanced activity and resistance to many β-lactamases.

✔ Once-Daily Dosing (in many cases)
Long half-life allows convenient dosing, depending on clinical need.

✔ Bactericidal Action
Works by inhibiting bacterial cell wall synthesis, leading to cell death.

✔ Used for Multiple Infections
Commonly indicated for respiratory tract infections, urinary tract infections, skin and soft-tissue infections, septicemia, meningitis, bone & joint infections, etc.

✔ Suitable for IM/IV Administration
Can be administered as intramuscular or intravenous injection.

✔ High Tissue Penetration
Achieves effective concentrations in CSF, lungs, and other tissues.

✔ Stable Against Many Enzymes
Offers improved resistance to destruction by bacterial β-lactamase enzym

• Effective against a wide range of Gram-positive and Gram-negative bacteria.

• Belongs to the third-generation cephalosporin group.

• The 250 mg strength is suitable for mild to moderate infections or pediatric dosing as per physician guidance.

• Works by inhibiting bacterial cell wall synthesis, leading to rapid bacterial destruction.

• Long half-life allows reduced dosing frequency, enhancing patient compliance.

• Can be administered via IM (intramuscular) or IV (intravenous) route depending on clinical requirement.

• Commonly used for:

  • Respiratory tract infections

  • Urinary tract infections

  • Skin & soft tissue infections

  • Bone & joint infections

  • Abdominal infections

  • ENT infections

  • Gonorrhea (as per guidelines)

• Excellent distribution into body tissues, ensuring effective therapeutic levels.

• Well tolerated with minimal adverse effects when used as prescribed.

• Powder for injection I.P. ensuring longer shelf life and reliable reconstitution.

✔ Broad-Spectrum Antibiotic
Effective against a wide range of gram-positive and gram-negative bacteria.

✔ Third-Generation Cephalosporin
Provides enhanced stability against β-lactamases, improving antibacterial action.

✔ Once or Twice Daily Dosing
Long half-life allows convenient dosing schedules.

✔ Rapid Onset of Action
Quickly achieves therapeutic levels in blood for fast infection control.

✔ High Tissue Penetration
Reaches effective concentrations in lungs, urinary tract, skin, soft tissue, bones, and CSF.

✔ Used for Multiple Infections
Indicated for respiratory tract infections, urinary tract infections, skin infections, intra-abdominal infections, septicemia, meningitis, etc.

✔ Suitable for Hospital & Clinical Use
Available as sterile powder for IV/IM administration.

✔ Well-Tolerated
Generally safe with a favorable safety profile when used as prescribed.

FEATURES OF AMIKACIN 500MG INJECTION:

1. Composition:
   Each vial contains Amikacin Sulphate equivalent to Amikacin 500 mg.

2. Class:
   Aminoglycoside antibiotic.

3. Mechanism of Action:
   Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, leading to cell death.

4. Spectrum of Activity:
   Broad-spectrum — effective against Gram-negative bacteria (e.g., E. coli, Pseudomonas, Klebsiella, Proteus) and some Gram-positive organisms (e.g., Staphylococcus aureus).

5. Indications:
   Used in the treatment of severe bacterial infections such as:

   • Respiratory tract infections

   • Urinary tract infections

   • Intra-abdominal infections

   • Bone and joint infections

   • Septicemia

   • Skin and soft tissue infections

6. Dosage Form:
   Sterile injection for intramuscular (IM) or intravenous (IV) administration.

7. Onset & Duration:
   Rapid onset of action with a relatively short plasma half-life.

8. Storage:
   Store below 25°C, protected from light and moisture. Do not freeze.

9. Packaging:
   Usually available in 2 mL or 2.5 mL vials (containing 500 mg).

10. Special Features:

    • Broad-spectrum bactericidal activity

    • Effective against resistant Gram-negative organisms

    • Useful in hospital-acquired infections

    • Can be used in combination with other antibiotics for synergistic effect

✔ Broad-Spectrum Antibacterial Action
Combines Ceftriaxone, a third-generation cephalosporin, with Sulbactam, a β-lactamase inhibitor for enhanced efficacy.

✔ Effective Against Resistant Strains
Sulbactam protects Ceftriaxone from β-lactamase–mediated degradation, making the combination effective against resistant Gram-positive and Gram-negative bacteria.

✔ Wide Clinical Applications
Useful in treating respiratory tract infections, urinary tract infections, intra-abdominal infections, skin & soft tissue infections, bone & joint infections, and septicemia.

✔ Enhanced Therapeutic Outcome
The synergistic combination improves bactericidal activity and broadens the antimicrobial spectrum.

✔ Convenient Once or Twice Daily Dosing
Due to Ceftriaxone’s long half-life, ensuring better patient compliance and effective plasma concentrations.

✔ Parenteral Administration
Available for IV or IM use, providing quick onset of action in moderate to severe infections.

✔ Stable Formulation
Maintains potency and stability when reconstituted with appropriate solvents.

✔ Commonly Used in Hospital Settings
Preferred in emergency and inpatient care for moderate to severe infections requiring broad antimicrobial coverage.

• Broad-spectrum antibacterial coverage, effective against a wide range of gram-positive and gram-negative organisms.

• Beta-lactamase inhibitor combination: Tazobactam protects Piperacillin from enzymatic degradation, enhancing effectiveness.

• Indicated for severe infections, including respiratory tract infections, intra-abdominal infections, skin & soft tissue infections, urinary tract infections, and septicemia.

• Effective against Pseudomonas aeruginosa, making it suitable for hospital-acquired infections.

• Given via IV route for rapid therapeutic action.

• Synergistic bactericidal activity due to combined mechanism of action.

• Well-established safety profile with predictable clinical response.

• Available in multiple strengths (commonly 2.25g, 4.5g, etc.) for dose flexibility.

• Contains Mupirocin 2%, a potent topical antibacterial agent.

• Effective against Gram-positive bacteria, especially Staphylococcus aureus, including many strains causing skin infections.

• Used for treating primary skin infections such as impetigo, folliculitis, and furunculosis.

• Helpful in secondary skin infections like infected eczema or minor traumatic lesions.

• Topical application ensures localized action with minimal systemic absorption.

• Provides rapid relief from redness, swelling, and bacterial load in affected areas.

• Suitable for short-term treatment, usually applied 2–3 times a day as advised.

• Good tolerability, with mild and rare side effects such as slight burning or itching.

• Convenient ointment base that provides better adherence to moist or injured skin.